Pharmaceutical Regulatory Affairs plays a pivotal role in ensuring the safety, efficacy, and quality of pharmaceutical products, acting as the liaison between pharmaceutical companies and regulatory authorities. This dynamic field navigates the complex landscape of regulations and guidelines, shaping the development, manufacturing, and marketing of drugs.
Professionals in Regulatory Affairs are responsible for interpreting and implementing regulatory requirements to ensure compliance throughout the drug development lifecycle. They work closely with cross-functional teams to strategize and execute regulatory submissions, seeking approvals from health authorities such as the FDA, EMA, and other regulatory bodies worldwide.
The regulatory landscape is ever-evolving, and Regulatory Affairs professionals stay abreast of changes, guiding companies through the intricacies of new guidelines and ensuring adherence to established standards. They contribute to the successful launch and post-marketing surveillance of pharmaceutical products, addressing challenges related to labeling, safety reporting, and product recalls.
Pharmaceutical Regulatory Affairs professionals also play a crucial role in fostering international harmonization, facilitating global drug development and access. Their expertise is instrumental in navigating the complex web of regulations, ultimately contributing to the availability of safe and effective medicines for patients worldwide.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia